NIMG-09. NONINVASIVE PERFUSION IMAGING BIOMARKER OF MALIGNANT GENOTYPE IN ISOCITRATE DEHYDROGENASE MUTANT GLIOMAS
Mureb M, Jain R, Poisson L, Littig I, Neto L, Wu C, Ng V, Patel S, Patel S, Serrano J, Kurz S, Cahill D, Bendszus M, von Deimling A, Placantonakis D, Golfinos J, Kickingereder P, Snuderl M, Chi A. NIMG-09. NONINVASIVE PERFUSION IMAGING BIOMARKER OF MALIGNANT GENOTYPE IN ISOCITRATE DEHYDROGENASE MUTANT GLIOMAS. Neuro-Oncology 2019, 21: vi163-vi163. PMCID: PMC6847952, DOI: 10.1093/neuonc/noz175.681.Peer-Reviewed Original ResearchCDKN2A/B homozygous deletionCopy number variationsHomozygous deletionHigher rCBVGenomic alterationsRelative cerebral blood volumeImmediate postoperative settingHigh perfusion areaCopy number statusCerebral blood volumeNon-invasive imaging biomarkerInformed treatment decisionsMalignant genotypePostoperative settingIDHwt glioblastomasRCBVCDKN2A/BIDHmutCNV analysisAstrocytomaBlood volumeTreatment decisionsPerfusion areaImaging biomarkersDNA hypomethylation